Exhibit 10.8 CERTAIN PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BASED UPON A REQUEST FOR CONFIDENTIAL TREATMENT. THE NON-PUBLIC INFORMATION HAS BEEN FILED WITH THE COMMISSION. LICENSE AGREEMENT between Bayer AG D-51368 Leverkusen Germany - hereinafter...License Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations
EXHIBIT 10.23 AGREEMENT, dated as of December 18, 2003 (this "Agreement"), among MEMORY PHARMACEUTICALS CORP., a Delaware corporation (the "Company"), DR. ERIC KANDEL (the "Consultant") and the other signatories hereto (the "Stockholders")...Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • Delaware
UNDERWRITING AGREEMENT UNDERWRITING AGREEMENTUnderwriting Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New York
INTRODUCTIONStrategic Alliance Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
INTRODUCTIONCollaboration and License Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
Exhibit 10.24 Amendment to Employment Agreement, dated as of February 27, 2004 (this "Agreement"), among Memory Pharmaceuticals Corp., a Delaware corporation (the "Company") and Axel Unterbeck (the "Executive") The Executive and the Company entered...Employment Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
Exhibit 4.7 Amendment to the Investor Rights Agreement dated as of February 27, 2004 (this "Amendment"), among Memory Pharmaceuticals Corp. and the investors set forth on the signature page hereto (the "Investors")...Investor Rights Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations
